Clinical Trial Update: XH001 (New Antigen Tumor Vaccine) Combined With Chemotherapy as Adjuvant Therapy in Pancreatic Cancer [NA]

View source ↗

Summary

This clinical trial update reports XH001, a new antigen tumor vaccine, being studied with chemotherapy as adjuvant therapy for pancreatic cancer; the study is n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• XH001 (XH001)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Pancreatic Cancer | NA | Status: NOT_YET_RECRUITING